CO4920215A1 - Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones - Google Patents

Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Info

Publication number
CO4920215A1
CO4920215A1 CO98005805A CO98005805A CO4920215A1 CO 4920215 A1 CO4920215 A1 CO 4920215A1 CO 98005805 A CO98005805 A CO 98005805A CO 98005805 A CO98005805 A CO 98005805A CO 4920215 A1 CO4920215 A1 CO 4920215A1
Authority
CO
Colombia
Prior art keywords
microns
percent
oxacarbazepine
film
particle size
Prior art date
Application number
CO98005805A
Other languages
English (en)
Spanish (es)
Inventor
Schlutermann Burkhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4184588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4920215(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4920215A1 publication Critical patent/CO4920215A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CO98005805A 1997-02-14 1998-02-05 Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones CO4920215A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH33197 1997-02-14

Publications (1)

Publication Number Publication Date
CO4920215A1 true CO4920215A1 (es) 2000-05-29

Family

ID=4184588

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98005805A CO4920215A1 (es) 1997-02-14 1998-02-05 Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Country Status (31)

Country Link
US (2) US20070036863A1 (cg-RX-API-DMAC7.html)
EP (1) EP0966287B1 (cg-RX-API-DMAC7.html)
JP (3) JP2000511935A (cg-RX-API-DMAC7.html)
KR (3) KR19980071337A (cg-RX-API-DMAC7.html)
CN (2) CN1170542C (cg-RX-API-DMAC7.html)
AR (1) AR011142A1 (cg-RX-API-DMAC7.html)
AT (1) ATE239481T1 (cg-RX-API-DMAC7.html)
AU (1) AU738030B2 (cg-RX-API-DMAC7.html)
BR (1) BR9807368A (cg-RX-API-DMAC7.html)
CA (1) CA2277791C (cg-RX-API-DMAC7.html)
CO (1) CO4920215A1 (cg-RX-API-DMAC7.html)
CY (1) CY2480B1 (cg-RX-API-DMAC7.html)
CZ (1) CZ298840B6 (cg-RX-API-DMAC7.html)
DE (1) DE69814367T2 (cg-RX-API-DMAC7.html)
DK (1) DK0966287T3 (cg-RX-API-DMAC7.html)
ES (1) ES2199422T3 (cg-RX-API-DMAC7.html)
HU (1) HU227807B1 (cg-RX-API-DMAC7.html)
ID (1) ID22348A (cg-RX-API-DMAC7.html)
MY (1) MY117582A (cg-RX-API-DMAC7.html)
NO (1) NO327486B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ336946A (cg-RX-API-DMAC7.html)
PE (1) PE58999A1 (cg-RX-API-DMAC7.html)
PL (1) PL193332B1 (cg-RX-API-DMAC7.html)
PT (1) PT966287E (cg-RX-API-DMAC7.html)
RU (1) RU2201218C2 (cg-RX-API-DMAC7.html)
SK (1) SK284503B6 (cg-RX-API-DMAC7.html)
TR (1) TR199901804T2 (cg-RX-API-DMAC7.html)
TW (1) TW529957B (cg-RX-API-DMAC7.html)
UY (1) UY24888A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998035681A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA981205B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
NZ532707A (en) 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
WO2005020968A2 (en) 2003-09-03 2005-03-10 Novartis Ag Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
PE20051156A1 (es) * 2004-03-22 2006-02-13 Novartis Ag Formulaciones de matriz orales que comprenden licarbazepina
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
US8367105B2 (en) 2004-11-10 2013-02-05 Teva Pharmaceutical Industries, Ltd. Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
ATE453384T1 (de) 2005-09-23 2010-01-15 Hoffmann La Roche Neue dosierformulierung
PT2404919E (pt) 2005-11-08 2013-10-22 Vertex Pharma Composto heterocíclico útil como um modulador de transportadores de cassete de ligação a atp
AU2006313009B2 (en) * 2005-11-10 2013-10-24 Alphapharm Pty Ltd Process to control particle size
US9034381B2 (en) 2005-11-10 2015-05-19 Alphapharm Pty Ltd Process to control particle size
CA2634879A1 (en) * 2006-01-31 2007-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of oxcarbazepine and methods for its preparation
US20070178164A1 (en) * 2006-01-31 2007-08-02 Sigal Blau Pharmaceutical formulations of oxcarbazepine and methods for its preparation
WO2007121523A1 (en) * 2006-04-21 2007-11-01 Alphapharm Pty Ltd Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
US20090196923A1 (en) 2006-04-26 2009-08-06 Jayanta Kumar Mandal Controlled release formulation comprising anti-epileptic drugs
US20080138403A1 (en) * 2006-12-08 2008-06-12 Sun Pharmaceutical Industries Ltd. Pharmaceutical dosage forms of oxcarbazepine
JP2010513324A (ja) 2006-12-21 2010-04-30 アルファファーム ピーティーワイ リミテッド 医薬化合物および医薬組成物
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
EP2146699A2 (en) * 2007-05-23 2010-01-27 Ratiopharm GmbH Pharmaceutical compositions comprising oxcarbazepine
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
HUE049642T2 (hu) 2007-12-07 2020-09-28 Vertex Pharma 3-(6-(1-(2,2-Difluorbenzo[d][1,3]dioxol-5-il)-ciklopropánkarboxamido)-3-metilpiridin-2-il)-benzoesav szilárd formái
ES2900353T3 (es) 2010-04-07 2022-03-16 Vertex Pharma Composiciones farmacéuticas de ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiriidin-2-il)benzoico y administración de las mismas
NZ727015A (en) 2012-01-25 2017-12-22 Vertex Pharma Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
CA2930199C (en) 2013-11-12 2022-10-25 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of cftr mediated diseases
CN103735527B (zh) * 2013-12-24 2014-09-10 武汉人福药业有限责任公司 一种奥卡西平片剂及其制备方法
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TW202444706A (zh) 2019-05-16 2024-11-16 瑞士商諾華公司 N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
JPS6257467A (ja) * 1985-09-06 1987-03-13 Asahi Glass Co Ltd コ−テイング剤組成物
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5478654A (en) * 1994-05-06 1995-12-26 Gencorp Inc. Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal
US6296873B1 (en) * 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones

Also Published As

Publication number Publication date
HK1024423A1 (en) 2000-10-13
CA2277791C (en) 2008-11-18
AR011142A1 (es) 2000-08-02
AU6622298A (en) 1998-09-08
KR20090037873A (ko) 2009-04-16
JP2000511935A (ja) 2000-09-12
MY117582A (en) 2004-07-31
DE69814367D1 (de) 2003-06-12
PL334959A1 (en) 2000-03-27
PL193332B1 (pl) 2007-02-28
KR20120079826A (ko) 2012-07-13
CY2480B1 (en) 2005-06-03
ZA981205B (en) 1998-08-14
CN1626093A (zh) 2005-06-15
ID22348A (id) 1999-09-30
HUP0000886A2 (hu) 2000-09-28
RU2201218C2 (ru) 2003-03-27
TR199901804T2 (xx) 1999-09-21
SK109899A3 (en) 2000-03-13
ATE239481T1 (de) 2003-05-15
CA2277791A1 (en) 1998-08-20
WO1998035681A1 (en) 1998-08-20
NO327486B1 (no) 2009-07-13
NO993919L (no) 1999-08-13
HU227807B1 (en) 2012-03-28
JP2006077029A (ja) 2006-03-23
DE69814367T2 (de) 2004-02-26
DK0966287T3 (da) 2003-08-25
KR19980071337A (ko) 1998-10-26
CZ298840B6 (cs) 2008-02-20
CN1170542C (zh) 2004-10-13
ES2199422T3 (es) 2004-02-16
UY24888A1 (es) 2000-12-29
CZ287999A3 (cs) 1999-11-17
US20070036863A1 (en) 2007-02-15
TW529957B (en) 2003-05-01
SK284503B6 (sk) 2005-05-05
HUP0000886A3 (en) 2002-10-28
US20080014269A1 (en) 2008-01-17
JP2010132694A (ja) 2010-06-17
PT966287E (pt) 2003-09-30
NZ336946A (en) 2001-02-23
CN1247471A (zh) 2000-03-15
AU738030B2 (en) 2001-09-06
EP0966287A1 (en) 1999-12-29
BR9807368A (pt) 2000-03-14
EP0966287B1 (en) 2003-05-07
PE58999A1 (es) 1999-06-25
NO993919D0 (no) 1999-08-13

Similar Documents

Publication Publication Date Title
PE58999A1 (es) Tabletas de oxacarbazepina recubiertas de pelicula
PE20110544A1 (es) Formulacion farmaceutica de liberacion controlada que comprende isomero r de lansoprazol
ES2124794T3 (es) Procedimiento para producir granulados finos.
CA2416109A1 (en) Solid dose nanoparticulate compositions
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AR024008A1 (es) Uso de microesferas biodegradables que liberan un agente anticancerigeno, para el tratamiento de glioblastoma, proceso para la preparacion de estasmicroesferas y suspension que contiene a las mismas
EA200500909A1 (ru) Модифицированное высвобождение фармацевтической композиции
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
NO20005394D0 (no) Legemiddelavleveringssammensetninger bestÕende av klebende mikrosfærer
ATE295155T1 (de) Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
ATE332126T1 (de) Geschmacksmaskierte pharmazeutische zusammensetzungen
NZ573555A (en) Nanoparticulate posaconazole formulations
MY149156A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
CA2489407A1 (en) Lasofoxifene tablet and its coating
GB0204772D0 (en) Pharmaceutical dosage forms
TW200635617A (en) Multiparticulate pharmaceutical form comprising mucoadhesively formulated nucleic acid active ingredients, and a process for producing the pharmaceutical form
JP2012001460A (ja) 光過敏性薬物の安定化法
TW200615692A (en) Radiation sensitive composition and method for the preparation of the same
AU2366501A (en) Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases
DE60322228D1 (de) Schnell zerfallende tablette
WO2004016242A3 (en) A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
UY26176A1 (es) Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas.
EP1922061B8 (en) Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
ECSP982406A (es) Tabletas de oxacarbazepina recubiertas de pelicula